Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference301 articles.
1. Characteristics of SARS-CoV-2 and COVID-19;Hu;Nat. Rev. Microbiol.,2021
2. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study;Wu;Lancet,2020
3. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor;Hoffmann;Cell,2020
4. A pneumonia outbreak associated with a new coronavirus of probable bat origin;Zhou;Nature,2020
5. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV;Ou;Nat. Commun.,2020
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nanomaterial-Driven Precision Immunomodulation: A New Paradigm in Therapeutic Interventions;Cancers;2024-05-27
2. The potential application of complement inhibitors-loaded nanosystem for autoimmune diseases via regulation immune balance;Journal of Drug Targeting;2024-03-21
3. Pharmaceutical liposomal delivery—specific considerations of innovation and challenges;Biomaterials Science;2023
4. Current Treatments for COVID-19: Application of Supercritical Fluids in the Manufacturing of Oral and Pulmonary Formulations;Pharmaceutics;2022-11-04
5. Editorial to “Journey into the immunological properties of engineered nanomaterials: There and back again”;Advanced Drug Delivery Reviews;2022-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3